Related Experiment Video

Updated: Jun 29, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
09:21

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke

Published on: January 18, 2018

Treatment of intracranial atherosclerotic stenosis

Tanya N Turan1, Marc I Chimowitz

  • 1Department of Neurosciences, Division of Neurology, Medical University of South Carolina, Charleston, SC, USA.

Reviews in Neurological Diseases
|October 8, 2008
PubMed

Insights

Atherosclerotic stenosis in major brain arteries causes ischemic stroke. Aggressive medical treatment and antiplatelet drugs are key for prevention, but more research is needed on angioplasty and stenting effectiveness.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Atherosclerotic stenosis of intracranial arteries is a significant cause of ischemic stroke.
  • Current management includes antiplatelet agents and risk factor control (e.g., hypertension).
  • Angioplasty and stenting are available therapeutic options for intracranial arterial stenosis.

Purpose of the Study:

  • To evaluate the optimal treatment strategy for patients with severe symptomatic intracranial arterial stenosis.
  • To compare the efficacy of aggressive medical therapy alone versus intracranial stenting combined with aggressive medical therapy.

Main Methods:

  • The study proposes a randomized controlled trial.
  • The trial will compare aggressive medical therapy with aggressive medical therapy plus intracranial stenting.
  • Participants will include patients with severe symptomatic intracranial stenosis.

Main Results:

  • The abstract does not contain specific results as it outlines a proposed trial.
  • Further research is needed to determine the optimal treatment approach.

Conclusions:

  • Aggressive medical management and antiplatelet therapy are crucial for preventing vascular events in intracranial arterial stenosis.
  • A randomized controlled trial is necessary to establish the role of intracranial stenting in addition to medical therapy for severe symptomatic cases.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...